Susquehanna International Group
INMB icon

Susquehanna International Group’s INmune Bio INMB Stock Holding History

Susquehanna International Group’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$220K Sell
194,391
-56,519
-23% -$80.5K ﹤0.01% 11508
2025
Q4 		$391K Buy
250,910
+93,956
+60% +$168K ﹤0.01% 9339
2025
Q3 		$325K Buy
156,954
+137,009
+687% +$314K ﹤0.01% 9931
2025
Q2 		$46.1K Sell
19,945
-20,350
-51% -$149K ﹤0.01% 12137
2025
Q1 		$315K Buy
40,295
+16,800
+72% +$133K ﹤0.01% 9969
2024
Q4 		$110K Buy
+23,495
New +$122K ﹤0.01% 11263
2024
Q3 		– Sell
-42,772
Closed -$304K – 12469
2024
Q2 		$377K Sell
42,772
-112,062
-72% -$1.1M ﹤0.01% 8934
2024
Q1 		$1.82M Buy
154,834
+110,998
+253% +$1.34M ﹤0.01% 5555
2023
Q4 		$494K Buy
43,836
+11,995
+38% +$101K ﹤0.01% 8697
2023
Q3 		$218K Sell
31,841
-9,170
-22% -$76K ﹤0.01% 10048
2023
Q2 		$372K Sell
41,011
-29,626
-42% -$238K ﹤0.01% 8996
2023
Q1 		$456K Buy
70,637
+56,343
+394% +$454K ﹤0.01% 8790
2022
Q4 		$90.6K Sell
14,294
-9,479
-40% -$67.3K ﹤0.01% 11043
2022
Q3 		$147K Buy
+23,773
New +$209K ﹤0.01% 11266
2022
Q2 		– Sell
-52,042
Closed -$387K – 13380
2022
Q1 		$438K Sell
52,042
-38,536
-43% -$346K ﹤0.01% 9314
2021
Q4 		$924K Buy
90,578
+8,049
+10% +$119K ﹤0.01% 7515
2021
Q3 		$1.6M Buy
82,529
+6,815
+9% +$132K ﹤0.01% 6312
2021
Q2 		$1.33M Buy
75,714
+42,642
+129% +$575K ﹤0.01% 6961
2021
Q1 		$393K Buy
+33,072
New +$595K ﹤0.01% 10022
2020
Q2 		– Sell
-11,443
Closed -$38K – 10495
2020
Q1 		$38K Buy
+11,443
New +$51.7K ﹤0.01% 9766

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Susquehanna International Group's INMB Position: Q1 2026 in Review

Susquehanna International Group reduced its INmune Bio (INMB) stake by 23% in Q1 2026, selling an estimated $80.5K and leaving 194,391 shares worth $220K. The position accounts for ﹤0.01% of the portfolio, ranked #11508.

Susquehanna International Group first reported a position in INMB in Q1 2020 and has held it in 20 quarters since. The position peaked at $1.82M in Q1 2024. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

  • Susquehanna International Group held 194,391 shares of INmune Bio worth $220K as of Q1 2026.
  • Susquehanna International Group sold 56,519 INmune Bio shares in Q1 2026, an estimated $80.5K.
  • INmune Bio made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11508 holding.
  • Susquehanna International Group first reported a position in INmune Bio in Q1 2020 and has held it in 20 quarters since.
  • Susquehanna International Group's INmune Bio position peaked at $1.82M in Q1 2024.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.